AHP Planning Red Clover Monograph

October 21, 2002

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


AHP Planning Red Clover Monograph

SCOTTS VALLEY, Calif.--The American Herbal Pharmacopoeia (AHP)announced plans to expedite the completion of its monograph on red clover, giventhe concerns about conventional hormone replacement therapy (HRT). Red clover isrich in isoflavones that may be beneficial for the management of menopausalsymptoms.

AHP's red clover monograph is to be developed by a group of physicians andpharmacists, including those affiliated with Harvard Medical School andMassachusetts General Hospital. The organization is requesting financial andtechnical assistance from interested industry members to complete the monographquickly; information is available from Roy Upton, executive director, [email protected].

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like